Bosh sahifaSHTDF • OTCMKTS
add
Sinopharm Group Co Ltd
Yopilish kursi
1,97 $
Yillik diapazon
1,97 $ - 2,95 $
Bozor kapitalizatsiyasi
63,04 mlrd HKD
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
HKG
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 147,46 mlrd | -5,13% |
Joriy xarajat | 6,38 mlrd | -2,07% |
Sof foyda | 2,28 mlrd | -9,16% |
Sof foyda marjasi | 1,55 | -4,32% |
Har bir ulushga tushum | — | — |
EBITDA | 5,57 mlrd | -12,42% |
Amaldagi soliq stavkasi | 21,74% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 43,33 mlrd | 26,05% |
Jami aktivlari | 429,58 mlrd | 2,85% |
Jami passivlari | 307,15 mlrd | 0,84% |
Umumiy kapital | 122,43 mlrd | — |
Tarqatilgan aksiyalar | 3,12 mlrd | — |
Narxi/balansdagi bahosi | 0,08 | — |
Aktivlardan daromad | 2,96% | — |
Kapitaldan daromad | 5,84% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 2,28 mlrd | -9,16% |
Operatsiyalardan naqd pul | 6,49 mlrd | 346,39% |
Sarmoyadan naqd pul | -1,29 mlrd | -269,35% |
Moliyadan naqd pul | -602,70 mln | -425,16% |
Naqd pulning sof oʻzgarishi | 4,59 mlrd | 374,61% |
Boʻsh pul | -22,56 mlrd | 29,73% |
Haqida
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Tashkil etilgan
2003
Sayt
Xodimlar soni
113 635
